Literature DB >> 15026343

Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma.

Rob A Cairns1, Richard P Hill.   

Abstract

An orthotopic mouse model of cervical carcinoma has been used to investigate the relationship between acute (cyclic) hypoxia and spontaneous lymph node metastasis in vivo. The human cervical carcinoma cell line ME-180 was stably transfected to express the fluorescent protein DsRed2, which allowed the in vivo optical monitoring of tumor growth and metastasis by fluorescent microscopy. The surgically implanted primary tumors metastasize initially to local lymph nodes and later to lung, a pattern consistent with the clinical course of the disease. The effect of acute hypoxia on the growth and spread of these tumors was examined by exposing tumor-bearing mice to treatment consisting of exposure to 12 cycles of 10 min 7% O(2) followed by 10 min air (total 4 h) daily during tumor growth. After 21 days, the tumors were excised, lymph node and lung metastases were quantified, and the hypoxic fraction and relative vascular area of the primary tumors were assessed by immunohistochemical staining for the hypoxic marker drug EF5 [2-(2-nitro-1H-imidazole-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] and the vascular marker CD31, respectively. In untreated mice, the primary tumor size was directly correlated with lymph node metastatic burden. The acute hypoxia treatment resulted in a significant decrease in the size of the primary tumors at the time of excision. However, the mice in the acute hypoxia group had an increased number of positive lymph nodes (2-4) as compared with control mice (1-3). Lung metastasis was not affected. The acute hypoxia treatment also decreased the relative vascular area in the primary tumors but did not affect the hypoxic fraction. These results suggest that fluctuating oxygenation in cervical carcinoma tumors may reduce tumor growth rate, but it may also enhance the ability of tumor cells to metastasize to local lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026343     DOI: 10.1158/0008-5472.can-03-3196

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  68 in total

1.  Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice.

Authors:  Hironobu Yasui; Shingo Matsumoto; Nallathamby Devasahayam; Jeeva P Munasinghe; Rajani Choudhuri; Keita Saito; Sankaran Subramanian; James B Mitchell; Murali C Krishna
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

2.  Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy.

Authors:  Davide Franceschini; Fabiola Paiar; Calogero Saieva; Pierluigi Bonomo; Benedetta Agresti; Icro Meattini; Daniela Greto; Monica Mangoni; Fiammetta Meacci; Mauro Loi; Giacomo Zei; Lorenzo Livi; Giampaolo Biti
Journal:  Radiol Med       Date:  2015-09-24       Impact factor: 3.469

Review 3.  Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity.

Authors:  Chao Liu; Qun Lin; Zhong Yun
Journal:  Radiat Res       Date:  2015-05-04       Impact factor: 2.841

4.  Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins.

Authors:  Michael P Hay; Kevin O Hicks; Karin Pchalek; Ho H Lee; Adrian Blaser; Frederik B Pruijn; Robert F Anderson; Sujata S Shinde; William R Wilson; William A Denny
Journal:  J Med Chem       Date:  2008-10-11       Impact factor: 7.446

5.  Cathepsin L in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor KGP94.

Authors:  Dhivya R Sudhan; Maria B Rabaglino; Charles E Wood; Dietmar W Siemann
Journal:  Clin Exp Metastasis       Date:  2016-04-07       Impact factor: 5.150

Review 6.  Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

Authors:  John M L Ebos; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2011-03-01       Impact factor: 66.675

Review 7.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

Review 8.  Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response.

Authors:  S R McKeown
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

9.  Measuring tumor cycling hypoxia and angiogenesis using a side-firing fiber optic probe.

Authors:  Bing Yu; Amy Shah; Bingqing Wang; Narasimhan Rajaram; Quanli Wang; Nirmala Ramanujam; Gregory M Palmer; Mark W Dewhirst
Journal:  J Biophotonics       Date:  2012-12-14       Impact factor: 3.207

10.  Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole.

Authors:  Mohammad H Pourgholami; Zhao Y Cai; Samina Badar; Kiran Wangoo; Marianne S Poruchynsky; David L Morris
Journal:  BMC Cancer       Date:  2010-04-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.